Filing Details
- Accession Number:
- 0001144204-10-021797
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-22 13:00:00
- Reporting Period:
- 2010-04-21
- Filing Date:
- 2010-04-22
- Accepted Time:
- 2010-04-22 19:50:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1174228 | Nurx Pharmaceuticals Inc. | NUXP.OB | Medicinal Chemicals & Botanical Products (2833) | 870681500 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1359866 | Sharyar Baradaran | 414 North Camden Drive #1240 Beverly Hills CA 90210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-21 | 2,777,778 | $0.00 | 2,777,778 | No | 4 | P | Indirect | Baradaran Revocable Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Baradaran Revocable Trust |
Footnotes
- The reporting person acquired the shares of common stock pursuant to a certain Stock Purchase Agreement dated as of April 9, 2010 for an aggregate purchase price of $250,000.
- The reporting person may be deemed to have voting and investment control over the shares held by the Baradaran Revocable Trust. Mr. Baradaran disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.